Labcorp Holdings Inc (LH)
238.64
+3.43
(+1.46%)
USD |
NYSE |
Nov 18, 16:00
238.72
+0.08
(+0.03%)
Pre-Market: 20:00
Labcorp Holdings Enterprise Value: 25.21B for Nov. 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2024 | 25.21B |
| November 15, 2024 | 24.92B |
| November 14, 2024 | 25.17B |
| November 13, 2024 | 25.84B |
| November 12, 2024 | 25.68B |
| November 11, 2024 | 25.65B |
| November 08, 2024 | 25.52B |
| November 07, 2024 | 25.24B |
| November 06, 2024 | 24.85B |
| November 05, 2024 | 24.41B |
| November 04, 2024 | 24.25B |
| November 01, 2024 | 24.24B |
| October 31, 2024 | 24.34B |
| October 30, 2024 | 24.53B |
| October 29, 2024 | 24.33B |
| October 28, 2024 | 24.27B |
| October 25, 2024 | 24.39B |
| October 24, 2024 | 24.51B |
| October 23, 2024 | 23.66B |
| October 22, 2024 | 23.71B |
| October 21, 2024 | 23.17B |
| October 18, 2024 | 23.31B |
| October 17, 2024 | 23.26B |
| October 16, 2024 | 23.39B |
| October 15, 2024 | 23.39B |
| Date | Value |
|---|---|
| October 14, 2024 | 23.40B |
| October 11, 2024 | 23.36B |
| October 10, 2024 | 23.24B |
| October 09, 2024 | 23.29B |
| October 08, 2024 | 23.05B |
| October 07, 2024 | 23.00B |
| October 04, 2024 | 23.33B |
| October 03, 2024 | 23.25B |
| October 02, 2024 | 23.58B |
| October 01, 2024 | 23.60B |
| September 30, 2024 | 23.96B |
| September 27, 2024 | 23.46B |
| September 26, 2024 | 23.31B |
| September 25, 2024 | 23.17B |
| September 24, 2024 | 23.34B |
| September 23, 2024 | 23.68B |
| September 20, 2024 | 23.48B |
| September 19, 2024 | 23.67B |
| September 18, 2024 | 23.89B |
| September 17, 2024 | 23.88B |
| September 16, 2024 | 23.77B |
| September 13, 2024 | 23.38B |
| September 12, 2024 | 23.29B |
| September 11, 2024 | 23.15B |
| September 10, 2024 | 23.32B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.61B
Minimum
Mar 23 2020
29.16B
Maximum
Dec 30 2021
23.15B
Average
22.80B
Median
Feb 22 2024
Enterprise Value Benchmarks
| Delcath Systems Inc | 299.43M |
| Star Equity Holdings Inc | 37.00M |
| Exact Sciences Corp | 10.72B |
| CytoSorbents Corp | 58.97M |
| Progyny Inc | 947.91M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 169.30M |
| Revenue (Quarterly) | 3.282B |
| Total Expenses (Quarterly) | 3.010B |
| EPS Diluted (Quarterly) | 2.00 |
| Gross Profit Margin (Quarterly) | 27.56% |
| Profit Margin (Quarterly) | 5.16% |
| Earnings Yield | 2.16% |
| Operating Earnings Yield | 5.62% |
| Normalized Earnings Yield | 3.586 |